We are proud to have a world-class team of scientists, engineers, clinicians, and key opinion leaders deeply engaged in the product development and clinical translation. Pandorum's efforts towards clinical translation of its products have been supported by renowned medical Institutions such as, are Northwestern Medicine (Chicago, US), Medical University of South Carolina (Charleston, US) and Dr. Shroff’s Charity Eye Hospital (New Delhi, India). Pandorum is also proud to be an Endless Frontier Labs (EFL) start-up, NYU Stern School of Business, Life Sciences Cohort -2023.
Startup Description
Since our inception in 2011 as a biotech startup from the top most academic institution in India, we have been supported by the host of marquee partners including India’s nodal biotech innovation agency BIRAC as well as top venture capitalists in India. Pandorum Technology is a tissue engineering and regenerative medicine company that uses the foundational and translational principles of biology and engineering to design world-class therapeutic products, that aim to alleviate the health conditions of patients suffering from corneal dystrophies, lung-related disorders, and liver diseases. We are at the cusp of reaching clinical stage and our commitment is to excellent translational science to positively impact human health.
Pandorum has built world class strengths to develop a range of deep proprietary platform technologies in modulating stem cell derived exosomes and priming them to deliver therapeutic cargos. Pandorum also has extensive capabilities in building 3D functional tissues through a combination of cells, gels, and cell modulators, using self-assembly, 3D printing, and other fabrication methods to construct desired tissue like micro-architecture. Our proprietary technology platform is designed to develop functional human tissues, such as bio-engineered Cornea and Liver, intended for medical research and therapeutic applications. We’re further expanding an arm in the area of cell-free therapies/stepping in the cell-free therapy for tissue repair and regeneration.
Product Screenshots
Business Model
Pandorum is a biotechnology company based out of the US and India, working in the field of Tissue Engineering and Regenerative Medicine. With its distinct synergy of life science, engineering, and clinical competencies, at Pandorum, we have developed a proprietary technology platform that combines therapeutic exosomes with anti-inflammatory, anti-fibrotic properties derived from clinical-grade human stem cells and biomaterials with tissue-mimetic properties – to promote efficient regeneration of human tissues, such as cornea, liver, and lung. Pandorum has been supported by several Govt. grants (BIG, SBIRI) and awards, and has raised funding from marquee investors and VCs.
Customers
based in
Africa (excluding North Africa), Australia & New Zealand (Oceania)
Business
Modal Type
Maturity
Type of
Sales
B2B
Competitors
Na
Teams
Tuhin Bhowmick
CEO & Director
Arun Chandru
CTO & Director
Abhinav Kumar
Associate Director
Are all the founders full-time on this
project?
Yes
Looking for an
opportunity to invest in companies
like Pandorum?
